- Lobbying
- Lobbying by Pulmatrix, Inc.
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Donald "Dack" Dalrymple | Principal and Managing Director |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Army - Dept of (Other)
Centers For Disease Control & Prevention (CDC)
Defense - Dept of (DOD)
Defense Advanced Research Projects Agency (DARPA)
Defense Threat Reduction Agency (DTRA)
Executive Office of the President (EOP)
Food & Drug Administration (FDA)
Government Accountability Office (GAO)
Health & Human Services - Dept of (HHS)
Homeland Security - Dept of (DHS)
Natl Institutes of Health (NIH)
State - Dept of (DOS)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Army - Dept of (Other)
Centers For Disease Control & Prevention (CDC)
Defense - Dept of (DOD)
Defense Advanced Research Projects Agency (DARPA)
Defense Threat Reduction Agency (DTRA)
Executive Office of the President (EOP)
Food & Drug Administration (FDA)
Government Accountability Office (GAO)
Health & Human Services - Dept of (HHS)
Homeland Security - Dept of (DHS)
Natl Institutes of Health (NIH)
State - Dept of (DOS)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Army - Dept of (Other)
Centers For Disease Control & Prevention (CDC)
Defense - Dept of (DOD)
Defense Advanced Research Projects Agency (DARPA)
Defense Threat Reduction Agency (DTRA)
Executive Office of the President (EOP)
Food & Drug Administration (FDA)
Government Accountability Office (GAO)
Health & Human Services - Dept of (HHS)
Homeland Security - Dept of (DHS)
Natl Institutes of Health (NIH)
State - Dept of (DOS)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Army - Dept of (Other)
Centers For Disease Control & Prevention (CDC)
Defense - Dept of (DOD)
Defense Advanced Research Projects Agency (DARPA)
Defense Threat Reduction Agency (DTRA)
Executive Office of the President (EOP)
Food & Drug Administration (FDA)
Government Accountability Office (GAO)
Health & Human Services - Dept of (HHS)
Homeland Security - Dept of (DHS)
Natl Institutes of Health (NIH)
State - Dept of (DOS)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Army - Dept of (Other)
Centers For Disease Control & Prevention (CDC)
Defense - Dept of (DOD)
Defense Advanced Research Projects Agency (DARPA)
Defense Threat Reduction Agency (DTRA)
Executive Office of the President (EOP)
Food & Drug Administration (FDA)
Government Accountability Office (GAO)
Health & Human Services - Dept of (HHS)
Homeland Security - Dept of (DHS)
Natl Institutes of Health (NIH)
State - Dept of (DOS)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Army - Dept of (Other)
Centers For Disease Control & Prevention (CDC)
Defense - Dept of (DOD)
Defense Advanced Research Projects Agency (DARPA)
Defense Threat Reduction Agency (DTRA)
Executive Office of the President (EOP)
Food & Drug Administration (FDA)
Government Accountability Office (GAO)
Health & Human Services - Dept of (HHS)
Homeland Security - Dept of (DHS)
Natl Institutes of Health (NIH)
State - Dept of (DOS)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Army - Dept of (Other)
Centers For Disease Control & Prevention (CDC)
Defense - Dept of (DOD)
Defense Advanced Research Projects Agency (DARPA)
Defense Threat Reduction Agency (DTRA)
Executive Office of the President (EOP)
Food & Drug Administration (FDA)
Government Accountability Office (GAO)
Health & Human Services - Dept of (HHS)
Homeland Security - Dept of (DHS)
Natl Institutes of Health (NIH)
State - Dept of (DOS)
Type of Issue
Registration
Issue(s) they said they’d lobby about: Appropriations and government contracts for development of new therapeutics for prevention, prophylaxis, treatment and transmission of respiratory infectious diseases.
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Army - Dept of (Other)
Centers For Disease Control & Prevention (CDC)
Defense - Dept of (DOD)
Defense Advanced Research Projects Agency (DARPA)
Defense Threat Reduction Agency (DTRA)
Executive Office of the President (EOP)
Food & Drug Administration (FDA)
Government Accountability Office (GAO)
Health & Human Services - Dept of (HHS)
Homeland Security - Dept of (DHS)
Natl Institutes of Health (NIH)
State - Dept of (DOS)
Type of Issue
Registration
Issue(s) they said they’d lobby about: Pandemic Influenza, Infectious Disease and Biodefense Therapeutics Products R&D and acquisition funded by HHS, NIAID, CDC, DOD, DTRA, JPOCBD and related authorization and appropriations legislation.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate